Document Detail


Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study.
MedLine Citation:
PMID:  19756919     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate the clinical usefulness of positron emission tomography (PET) using (18)F-fluorodeoxyglucose (FDG) in patients with follow-up or suspected recurrent biliary cancer in a multicenter study. METHODS: We performed a retrospective review of 50 patients who underwent FDG-PET (either integrated PET/CT or manual fusion of dedicated PET and CT) scans for post-treatment surveillance of biliary cancer. Recurrence was suspected in 40 of these patients on the basis of tumor marker levels, and/or findings of conventional imaging (group A). Clinical findings in the remaining 10 patients showed them to be disease-free (group B). The diagnostic performance and clinical impact of PET were analyzed. RESULTS: Recurrence was confirmed in 28 out of the 40 patients in group A, and 1 of the 10 patients in group B. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET for detecting recurrence were 86% (25/29), 91% (19/21), and 88% (44/50), respectively. The one patient with recurrence in group B was correctly interpreted by PET. Positive test likelihood ratio and negative test likelihood ratio were increased from 1.69 to 9.05, and 0.08 to 0.32, respectively, after PET study. The findings of PET resulted in a change of management for 10 out of the 50 patients (20%) by initiating an unplanned treatment strategy (n = 7), by obviating the need for planned diagnostic procedures (n = 2), or by changing the treatment plan (n = 1). CONCLUSION: FDG-PET/CT or PET with CT yielded helpful information in patients with suspected recurrent biliary cancer.
Authors:
Kazuhiro Kitajima; Koji Murakami; Kakuko Kanegae; Nagara Tamaki; Tomohiro Kaneta; Hiroshi Fukuda; Kotaro Nakajima; Hirofumi Fujii; Ukihide Tateishi; Kazuo Kubota; Tsuyoshi Suga; Yuji Nakamoto
Related Documents :
16319609 - Diagnostic utility of positron emission tomography-computed tomography for predicting m...
2288659 - Radiology in the diagnosis and staging of renal cell carcinoma.
16474909 - Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scannin...
17541519 - Postmortem computed tomography and magnetic resonance imaging in a case of terminal-sta...
21076089 - Breast cancer: comparative effectiveness of positron emission mammography and mr imagin...
18424949 - Positron emission tomography/computed tomography and whole-body magnetic resonance imag...
17225049 - Ct-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm s...
2044589 - Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with ...
15334569 - Quantification of human atherosclerotic plaques using spatially enhanced cluster analys...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2009-09-12
Journal Detail:
Title:  Annals of nuclear medicine     Volume:  23     ISSN:  1864-6433     ISO Abbreviation:  Ann Nucl Med     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2010-01-29     Completed Date:  2010-05-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8913398     Medline TA:  Ann Nucl Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  709-15     Citation Subset:  IM    
Affiliation:
Department of Radiology, Dokkyo Medical University School of Medicine, Shimotuka-gun, Tochigi, 321-0293, Japan. kazu10041976@yahoo.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Biliary Tract Neoplasms / radiography,  radionuclide imaging*
Female
Fluorodeoxyglucose F18 / diagnostic use*
Humans
Male
Middle Aged
Positron-Emission Tomography*
Recurrence
Retrospective Studies
Sensitivity and Specificity
Tomography, X-Ray Computed
Whole Body Imaging*
Chemical
Reg. No./Substance:
63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hydroxyespintanol and schefflerichalcone: two new compounds from Uvaria scheffleri.
Next Document:  HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission...